References
- Astrup T., Albrechtsen O. K. Estimation of the plasminogen activator and the trypsin inhibitor in animal and human tissues. Scandinav. J. Clin. & Lab. Investigation 1957; 9: 233
- Astrup T., Müllertz S. The fibrin plate method for estimation fibrinolytic activity. Archiv. Biochem. Biophys 1952; 40: 346
- Astrup T., Stage A. A protease inhibitor in ox lung tissue. Acta chem. Scandinav 1956; 10: 617
- Astrup T., Sterndorff I. The plasminogen activator in urine and the urinary trypsin inhibitor. Scandinav. J. Clin. & Lab. Investigation 1955; 7: 239
- Faarvang H. J. The excretion of a trypsin inhibitor in urine as a general stress reaction. Transactions of the 6th Congress of the European Society of Haematology, Copenhagen 1957. Karger, Basel 1957; 477
- Faarvang H. J. The excretion of trypsin inhibitor in urine in normal persons. Acta Endocrinol 1959a; 30: 285
- Faarvang H. J. The excretion of trypsin inhibitor in urine during normal pregnancy. Acta Endocrinol 1959 b; 31: 117
- Lassen M. Heat denaturation of plasminogen in the fibrin plate method. Acta Physiol. Scandinav 1952; 27: 371
- Ploug J., Kjeldgaard N. O. Isolation of a plasminogen activator (urokinase) from urine. Arch. Biochem. Biophys 1956; 62: 500
- Shulman N. R. A proteolytic inhibitor with anticoagulant activity separated from human urine and plasma. J. Biol. Chem 1955; 213: 655